IRadimed stock gains institutional support as valuation stays near 52-week high
Published on 09/03/2026 at 18:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSIRadimed stock (ISIN US4627231087) is drawing attention on September 3, 2026, as a new institutional filing shows fresh buying and the Nasdaq-listed shares recently traded at 100.86 USD, close to their 52-week high of 102.59 USD according to data compiled by Morningstar.
Institutional buying underpins valuation
A new regulatory filing summarized by MarketBeat on September 3, 2026 reports that Man Group plc has initiated a position worth about 1.51 million USD in IRadimed Corporation shares.
The same MarketBeat overview notes that analysts currently assign the stock an average rating described as Moderate Buy with an average price target of 120.00 USD, suggesting upside potential of about 19% from the recent 100.86 USD level if those targets are met.
Share price near 52-week high
According to quote data from Morningstar as of early trading on September 3, 2026, IRMD most recently closed at 100.86 USD on Nasdaq, with an intraday trading range of 100.07 USD to 102.59 USD.
The same Morningstar data show a 52-week range of 47.48 USD to 102.59 USD, meaning the current price is slightly below the 52-week high and has more than doubled versus the 52-week low, a move that underlines how strongly the market has repriced the company in the past year.
More reports and background on IRadimed
Read further coverage, regulatory news and commentary on IRadimed Corporation to understand how the company positions itself in the medical device market and how analysts assess its long-term prospects.
IRadimed devices for MRI-compatible patient monitoring
IRadimed Corporation focuses on developing and selling MRI-compatible patient monitoring and infusion systems that allow hospitals to monitor vital signs and deliver medication during magnetic resonance imaging procedures without interfering with imaging quality.
IRadimed stock and investor view
Based on Morningstar data as of September 3, 2026, IRadimed stock trades on Nasdaq under the ticker IRMD at 100.86 USD, with that price sitting just below the 52-week high of 102.59 USD and well above the 52-week low of 47.48 USD, highlighting how the stock price has climbed over the past year.
IRadimed stock key data
- Company: IRadimed Corporation
- ISIN: US4627231087
- Ticker: IRMD
- Trading venue: NASDAQ
- Price (as of September 3, 2026): 100.86 USD
- Sector / Industry: Health Care / Medical Devices
- Index membership: None (major global benchmarks)
